MedTrace Logo

Chordal Repair for Transcatheter Mitral Valve Repair (TMVr)

NCT04281940 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 7

Last updated 2024-10-15

No results posted yet for this study

Summary

A multi-center evaluation of the Pipeline chordal repair system for treatment of clinically significant mitral regurgitation in subjects determined appropriate for mitral valve repair.

Conditions

  • Degenerative Mitral Valve Disease
  • Mitral Valve Regurgitation

Interventions

DEVICE

Transcatheter implantation of chordal repair system

Implantation of anchor via transcatheter delivery system to delivery chordal repair system tethering the mitral leaflets to the ventricle

Sponsors & Collaborators

  • Pipeline Medical

    lead INDUSTRY

Principal Investigators

  • Adrian Ebner, MD · Principal Investigator

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
30 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-03-18
Primary Completion
2023-06-07
Completion
2024-05-01

Countries

  • Georgia
  • Paraguay
  • Serbia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04281940 on ClinicalTrials.gov